TrialsgrambetaRCTs are beautiful

PIVOTAL

2019

Proactive IV Iron Therapy in Haemodialysis Patients

In 2,141 incident haemodialysis patients, proactive high-dose intravenous iron reduced death and cardiovascular events compared with a reactive low-dose regimen.

Result

Efficacy: Composite of death, MI, stroke or HF hospitalisationHR 0.85 (95% CI 0.73-1.00) · P = 0.04

Below 1 favours proactive high-dose intravenous iron, above 1 favours a reactive low-dose regimen.

Event rates
Absolute difference
3.0 points

The absolute difference is derived from the event rates.

Also reported: Also lowering the ESA dose.

Original publication
Subtopic
Iron therapy
Design
Open-label RCT
Relevance
Important: one of several pillars.
Source
Macdougall IC, et al. N Engl J Med. 2019;380(5):447-458.doi 10.1056/NEJMoa1810742

Discussion & critique

Higher iron dosing proved safe and effective without an excess infection signal.

Discussed in podcasts